Small coronary vessel angioplasty: outcomes and technical considerations
- PMID: 21057576
- PMCID: PMC2964944
- DOI: 10.2147/VHRM.S8161
Small coronary vessel angioplasty: outcomes and technical considerations
Abstract
Small vessel (<3 mm) coronary artery disease is common and has been identified as independent predictor of restenosis after percutaneous coronary intervention. It remains controversial whether bare-metal stent (BMS) implantation in small vessels has an advantage over balloon angioplasty in terms of angiographic and clinical outcomes. Introduction of drug-eluting stent (DES) has resulted in significant reduction in restenosis and the need for repeat revascularization. Several DESs have been introduced resulting in varying reduction in outcomes as compared with BMS. However, their impact on outcomes in small vessels is not clearly known. It is expected that DES could substantially reduce restenosis in smaller vessels. Large, randomized studies are warranted to assess the impact of different DESs on outcomes in patients with small coronary arteries.
Keywords: coronary artery disease; drug-eluting stent; restenosis; small coronary arteries; stent.
Similar articles
-
Percutaneous coronary intervention in small coronary vessels: from balloon angioplasty to drug eluting stent era.Indian Heart J. 2011 May-Jun;63(3):228-33. Indian Heart J. 2011. PMID: 22734340 Review.
-
Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.Am Heart J. 2013 Nov;166(5):920-6. doi: 10.1016/j.ahj.2013.08.023. Epub 2013 Oct 7. Am Heart J. 2013. PMID: 24176449 Clinical Trial.
-
Update on stents: recent studies on the TAXUS stent system in small vessels.Vasc Health Risk Manag. 2007;3(4):481-90. Vasc Health Risk Manag. 2007. PMID: 17969378 Free PMC article. Review.
-
Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.EuroIntervention. 2012 Aug;8(4):450-5. doi: 10.4244/EIJV8I4A71. EuroIntervention. 2012. PMID: 22917728 Clinical Trial.
-
Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.Circ Cardiovasc Interv. 2014 Dec;7(6):760-7. doi: 10.1161/CIRCINTERVENTIONS.113.001146. Epub 2014 Nov 4. Circ Cardiovasc Interv. 2014. PMID: 25371536 Clinical Trial.
Cited by
-
Novel drug-eluting stents in the treatment of de novo coronary lesions.Vasc Health Risk Manag. 2011;7:103-18. doi: 10.2147/VHRM.S11444. Epub 2011 Feb 25. Vasc Health Risk Manag. 2011. PMID: 21415924 Free PMC article. Review.
-
Best percutaneous coronary intervention approach for small caliber coronary arteries.J Thorac Dis. 2016 Oct;8(10):E1268-E1270. doi: 10.21037/jtd.2016.10.18. J Thorac Dis. 2016. PMID: 27867604 Free PMC article. No abstract available.
-
One-year clinical outcomes in patients with very small coronary artery disease treated with drug-eluting stents: An observational study in the Indian population.Indian Heart J. 2021 Nov-Dec;73(6):729-732. doi: 10.1016/j.ihj.2021.09.007. Epub 2021 Sep 20. Indian Heart J. 2021. PMID: 34686368 Free PMC article.
-
The Impact of Fractional Flow Reserve-Guided Coronary Revascularization in Patients with Coronary Stenoses of Intermediate Severity.Acta Cardiol Sin. 2017 Jul;33(4):353-361. doi: 10.6515/acs20170202b. Acta Cardiol Sin. 2017. PMID: 29033506 Free PMC article.
-
Percutaneous coronary intervention in side branch coronary arteries: Insights from the Japanese nationwide registry.Int J Cardiol Heart Vasc. 2021 Aug 18;36:100856. doi: 10.1016/j.ijcha.2021.100856. eCollection 2021 Oct. Int J Cardiol Heart Vasc. 2021. PMID: 34430704 Free PMC article.
References
-
- Mackay J, Menash G. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organisation, Centers for disease control and prevention; 2004.
-
- Wong P, Lau KW, Lim YL, Oesterele SN. Stent placement for non-STRESS/BENESTENT lesions: a critical review. Catheter Cardiovasc Interv. 2000;51:223–233. - PubMed
-
- O’Connor NJ, Morton JR, Birmeyer JD, Olmstead EM, O’Connor GT Northern New England Cardiovascular Disease Study Group. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Circulation. 1996;93:652–655. - PubMed
-
- Bauters C, Hubert E, Prat A, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 1998;31:1291–1298. - PubMed
-
- Serruys PW, Kay IP, Disco C, et al. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta analysis of the Belgian Netherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter ultrasound stent in coronaries. J Am Coll Cardiol. 1999;34:1067–1074. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources